Cleared Special

K253516 - Assert-IQ (DM5100) (FDA 510(k) Clearance)

Dec 2025
Decision
36d
Days
Class 2
Risk

K253516 is an FDA 510(k) clearance for the Assert-IQ (DM5100). This device is classified as a Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection) (Class II - Special Controls, product code MXD).

Submitted by Abbott Medical (Sylmar, US). The FDA issued a Cleared decision on December 18, 2025, 36 days after receiving the submission on November 12, 2025.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1025.

Submission Details

510(k) Number K253516 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 12, 2025
Decision Date December 18, 2025
Days to Decision 36 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code MXD — Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1025

Similar Devices — MXD Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection)

All 14
LUX-Dx II Insertable Cardiac Monitor (M302)
K252593 · Boston Scientific Corporation · Sep 2025
LINQ II™ Insertable Cardiac Monitor (ICM)
K240693 · Medtronic, Inc. · Mar 2024
LINQ II Insertable Cardiac Monitor
K233562 · Medtronic, Inc. · Dec 2023
LINQ II™ Insertable Cardiac Monitor (LNQ22)
K233320 · Medtronic, Inc. · Oct 2023
LUX-Dx II (M302)
K231328 · Boston Scientific Corp · Aug 2023
BIOMONITOR IV
K230375 · Biotronik, Inc. · May 2023